Schizophrenia is associated with significant cognitive impairment. Bipolar disorder (BD) also presents with cognitive deficits that are similar to, albeit less severe, than those reported in schizophrenia. There has been controversy over whether selective deficits in social cognition or developmental trajectory of cognitive deficits can distinguish schizophrenia from BD. Also, available studies have not generally considered the potential effect of cognitive heterogeneity within the two disorders on between-group differences. The current review examines the evidence on the specificity of social cognitive deficits and early neurocognitive impairment to schizophrenia and explores the overall outcome of studies investigating within and cross-diagnosis cognitive heterogeneity in schizophrenia and BD. Current evidence does not support the specificity of social cognitive impairment to schizophrenia. Available studies also suggest that cognitive impairment in premorbid and early stages is evident not only in schizophrenia but also in many BD patients. Both schizophrenia and BD have a number of cognitive subgroups, including severe impairment, good functioning, and one or more selective or modest impairment clusters. While both disorders are represented in each cognitive subgroup, there are significant cross-diagnostic differences regarding prevalences of individuals belonging to the severe impairment and good functioning subgroups. Individuals with schizophrenia are much more likely to exhibit severe cognitive impairment than individuals with BD and good cognitive functioning is more often observed in BD patients than schizophrenia patients. Further identification of the neurobiological and genetic characteristics of the cognitive subgroups in major psychoses can improve the validity of diagnostic systems and can advance the development of personalized management approaches, including cognitive remediation.
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Key words: bipolar disorder, cognition, heterogeneity, psychosis, schizophrenia. C OGNITIVE IMPAIRMENT IS a well-established and persistent feature of schizophrenia. [1] [2] [3] Cognitive deficits in schizophrenia have been recognized since the delineation of dementia praecox by Kraepelin. The range of cognitive deficits in schizophrenia is broad. Multiple cognitive domains, including verbal and visual memory, working memory, processing speed, attention, executive functions and social cognition, are impaired in schizophrenia. [2] [3] [4] Cognitive impairment in schizophrenia is clinically relevant and one of the most important determinants of functional impairment observed in this disorder. 5, 6 Persisting cognitive deficits and functional impairment had been traditionally considered as specific features of schizophrenia in comparison to manic-depressive psychoses. However, neither cognitive impairment nor functional deficits are specific to schizophrenia. Recent work within the last two decades has clearly shown that bipolar disorder (BD) is also associated with cognitive deficits and functional impairment, which are also evident in euthymic patients. [7] [8] [9] [10] While the severity of cognitive deficit is less severe in BD than in schizophrenia, evidence suggests that the profiles of cognitive deficits are similar in the two disorders. 3 Importantly, these findings contradict other observations, including evidence for a relation between BD and creativity and premorbid scholastic achivement. [11] [12] [13] However, it can be argued that methodological issues, such as the use of cross-sectional assessment, recruitment of patients with chronic illness, and lack of information about premorbid cognitive development in most studies, can limit our ability to show the potential cognitive differences between schizophrenia and BD. One argument is the specificity of early cognitive deficits to schizophrenia. 14, 15 It has been argued that cognitive impairment is evident in the prodromal stage and first-episode of schizophrenia but not in BD. Another notion is the specificity of cognitive deficits that are critical for communication and social functioning (social cognition) to schizophrenia. Theory of mind (ToM) and other social cognitive deficits (compared to non-social cognitive deficits) has been suggested to be more specific to schizophrenia. 16 Other authors have argued that difficulties in premorbid intellectual development can separate schizophrenia from BD. 17, 18 Finally, it is important to note that all of these three arguments about potential differences between schizophrenia and BD are based on the comparison between the two distinct disorders.
There is a substantial heterogeneity in the two disorders. Neurobiological and clinical evidence also suggests considerable overlap between schizophrenia and BD. 19 Familial and molecular genetic studies have suggested that there are susceptibility genes common to both disorders. However, it is important to note that familial and genetic studies also suggest that there is evidence for schizophrenia-and BDspecific genetic susceptibility factors. 20, 21 Available studies have also provided evidence suggesting that shared susceptibility genes can impair neurodevelopment and cognition. 22, 23 Therefore, it is expected that there should be considerable heterogeneity of cognitive performances within both disorders that can also affect the extent of differences between the two diagnostic categories. The majority of the available neurocognitive studies has not considered the relation between cognitive impairment and heterogeneity within the two disorders. In the first part of the current article, studies in schizophrenia and BD will be reviewed and the specificity of early neurocognitive impairment, social cognitive impairment, and premorbid deficits in the development of intellectual abilities to schizophrenia will be discussed. In the second part of the article, evidence for cognitive heterogeneity within schizophrenia and BD and the role of heterogeneity in explaining contradictory findings in previous studies will be explored.
EVIDENCE FOR SPECIFIC DIFFERENCES BETWEEN SCHIZOPHRENIA AND BD
Specificity of social cognitive deficits to schizophrenia in comparison to BD Social cognitive impairment in schizophrenia might be a particularly important contributor to functional impairment. [24] [25] [26] Deficits in emotion recognition and ToM are well-established findings in schizophrenia. [27] [28] [29] It was suggested that social cognitive impairment might be more specific than nonsocial cognitive impairment to schizophrenia. In a recent study, Lee et al. 16 found that BD patients showed less impairment on social relative to nonsocial cognitive performance, whereas schizophrenia patients showed more impairment on social relative to non-social cognitive performance. It might be argued that specificity of social cognitive impairment to schizophrenia can explain relatively severe functional impairment observed in schizophrenia compared to BD. However, there is also emerging evidence for social cognitive deficits in BD. 30 Similar to findings of neurocognitive studies, deficits with medium effect sizes in social cognition were observed in BD. 31, 32 Evidence also suggests that social cognitive deficits are evident not only during mood episodes but also during remission.
A number of recent studies investigating emotion recognition and ToM have directly compared performances of schizophrenia and BD. 16, 33, 34 A recent meta-analysis of social cognition explored differences between schizophrenia and BD patients. 35 This meta-analysis found that schizophrenia patients significantly but modestly underperformed patients with BD in both facial emotion recognition (d = 0.43) and ToM (d = 0.60). Effects sizes for differences between schizophrenia and BD were similar for social and non-social cognitive abilities. Previous meta-analyses of neurocognitive studies comparing schizophrenia and BD have also found similar effect sizes for differences between these two disorders. 36, 37 These findings suggest that differences between schizophrenia and BD on social cognitive deficits are quantitative only and there is a significant overlap of performances of patients with schizophrenia and those with BD in both the social and non-social cognitive domains.
Cognitive impairment in early years of BD and schizophrenia
Most of the available studies that compared schizophrenia and BD have included chronic patients. However, it has been suggested that cognitive impairment in BD and schizophrenia might have very different trajectories. In schizophrenia, it is well accepted that cognitive deficits are evident in firstepisode and in young adults who have a high clinical and genetic risk to schizophrenia. 38, 39 It was also hypothesized that patients with BD only develop cognitive deficits during the course of illness as a result of neurodegenerative changes and that cognitive deficits would be absent or very modest in firstepisode BD and premorbid stages of the illness. 15, 17 It has been argued that early onset cognitive impairment might be a specific feature of schizophrenia.
First-episode BD and schizophrenia
Recently, a number of studies investigating cognitive impairment in BD have been conducted in firstepisode BD and most of these studies have not supported the preserved cognition argument in firstepisode BD. Two recent meta-analyses of neuropsychological studies in first-episode BD have provided strong evidence for cognitive impairment in firstepisode BD. 40, 41 A meta-analysis by Bora and Pantelis suggested that deficits with medium to large effect sizes (d = 0.36-0.83) are evident in verbal and visual memory, processing speed, sustained attention, executive functions, working memory, and verbal fluency in first-episode BD. 40 The severity and pattern of such deficits in first-episode BD were similar to findings in chronic BD patients. 7, 8 Bora and Pantelis also found that cognitive impairment is significantly more severe in first-episode schizophrenia than first-episode BD but the severity of betweengroup differences was modest (d = 0.25-0.67). 40 This finding is similar to that established for chronic schizophrenia and BD and suggests that there is a significant overlap between cognitive performance in first-episode schizophrenia and BD.
High-risk studies
Cognitive impairment is already evident in youth with clinical high risk to psychosis. 39, 42 Clinical high-risk paradigms have been used to investigate cognitive impairment in BD in just a few studies. [43] [44] [45] However, emerging evidence suggests that cognitive impairment is also evident in individuals at clinical risk for BD. Metzler et al. 43 reported cognitive deficits in individuals meeting risk criteria for affective psychosis. Also, the ultra-high-risk (UHR) to psychosis paradigm, which was developed to detect early phases of schizophrenia, suggested that UHR is a nonspecific risk paradigm of psychosis and that a subset of UHR subjects develop BD at follow-up. Two recent studies in UHR to psychosis samples found that pre-onset neurocognitive deficits were evident in at-risk subjects who developed BD at follow-up. 44, 45 In the first study, Olvet et al. 44 found that global cognition is significantly impaired in at-risk subjects who developed BD at follow-up. In the second study, Ratheesh et al. 45 reported deficits in processing speed, executive functions, and general intellectual abilities in at-risk subjects who developed BD during follow-up in comparison to healthy controls.
It is also well established that youth with familial risk for schizophrenia have cognitive deficits, which are comparable to UHR subjects in severity. 39 While the number of studies investigating neurocognitive abilities in youth with familial high risk to BD is small, the available evidence also suggests that cognitive impairment is evident in young relatives of individuals with BD. [46] [47] [48] [49] [50] As a summary, the available evidence does not support the notion of specificity of cognitive impairment in the early stages to schizophrenia. Emerging evidence suggests that cognitive deficits are also evident in first-episode and at clinical and genetic risk to BD.
Differences in premorbid intellectual abilities between schizophrenia and BD

Intellectual disabilities in schizophrenia and BD
Childhood-onset intellectual disabilities are overrepresented in schizophrenia compared to healthy controls, and in people with intellectual disability, psychosis is more prevalent than in the general population. 51, 52 Morgan et al. 52 estimated the prevalence of intellectual disability in schizophrenia as 4.9%. In the same study, the prevalence of schizophrenia among individuals with intellectual disability was 4.4%.
In BD, there is less evidence for severe childhood-onset intellectual deficits. Some studies have not found significantly increased risk for BD in intellectual disability. 52 However, other evidence suggests that there might be a relation between intellectual disabilities and risk for BD. In a recent study, intellectual disabilities were more common in children of mothers with schizophrenia and BD. 53 Also, there is some evidence suggesting a significant relation between intellectual disability and rapid-cycling BD. 54 Some evidence also suggests that history of autism spectrum disorders, attention deficit hyperactivity disorder, and several other syndromes characterized by intellectual deficits might be associated with not only schizophrenia but also BD. [55] [56] [57] Premorbid cognitive deficits in childhood and adolescence in schizophrenia and BD
The existence of premorbid cognitive deficits in people with schizophrenia is well established. [58] [59] [60] [61] In many cases, premorbid IQ deficits and learning difficulties in childhood and adolescence precede adult schizophrenia. Evidence suggests that individuals who develop adult schizophrenia exhibit IQ deficit in their childhood (approximately 0.5 SD, 33% non-overlap with controls). 58, 59 The number of studies investigating premorbid cognitive deficits that precede BD is relatively modest. Several studies have not found any evidence of premorbid cognitive impairment in BD. [62] [63] [64] However, these studies have inadequate power to detect modest deficits as the number of subjects who developed BD was small. Two of three studies that had at least 100 subjects with BD found a relation between poor scholar achievement/cognitive function and risk for BD. 65, 66 In a population-based large national study including over 700 000 individuals, MacCabe et al. 65 investigated the relation between scholastic achievement at age 15-16 years and later hospital admissions for BD (280 individuals). The individuals with the poorest grades had a nearly twofold increased risk for BD. In a large cohort of 200 000 male subjects conscripted into the Finnish defense forces, Tiihonen et al. 67 investigated the relation between cognitive assessment and later hospital admission for BD (100 individuals) and found a relation between cognitive impairment in visuospatial abilities and increased risk for BD at follow-up.
Some evidence also suggests that premorbid cognitive deficits in childhood BD might precede adult BD. Seidman et al. 68 showed that children (mean age = 7 years) who developed BD or schizoaffective disorder, bipolar type in adulthood had cognitive deficits.
The effect size of this cognitive deficit was d = 0.3 and 23% of children had a significant neuropsychological impairment. In the same study, the effect size for cognitive deficits in the schizophrenia group was moderately larger, d = 0.57, and 42% of children had a significant cognitive impairment.
As a summary, while evidence for the relation between premorbid cognitive deficits and schizophrenia is stronger compared to BD, emerging evidence suggests that some patients with BD also have premorbid cognitive deficits. While contradictory findings exist, it seems that evidence does not overall support any of the three notions discussed in this section, including specificity of social cognition, and early and premorbid cognitive impairment, to schizophrenia. However, it is important to note that cognitive heterogeneity within and between schizophrenia and BD could have a significant impact on the findings of these studies.
HETEROGENEITY OF COGNITIVE IMPAIRMENT IN BD AND SCHIZOPHRENIA Cognitive subgroups in schizophrenia and BD
Cluster analytical studies in schizophrenia have consistently found several clusters of patients based on their cognitive performances. [69] [70] [71] [72] [73] [74] [75] [76] [77] In these studies, a subgroup of patients with schizophrenia were members of a neurocognitive cluster with very severe and widespread cognitive impairment. A smaller subgroup of patients was characterized with normal neuropsychological performance. The other patients in these studies have been clustered to one or more neurocognitive subgroups characterized by more moderate and selective deficits.
Relatively few studies have investigated neurocognitive subgroups in BD. Several studies have categorized BD patients into cognitively impaired and unimpaired groups based on arbitrary cut-off scores. 78, 79 These studies had a relatively small number of BD patients included (n = 50-110) and used variable cut-off scores, such as scoring 1-2 SD below controls or scoring at or below the fifth percentile. [78] [79] [80] [81] [82] [83] Findings of these studies suggest that around 40% of patients with BD have no neurocognitive deficits at all and other patients have variable levels of cognitive deficits. 79, 83 Studies using strict cut-off scores (such as 2 SD below) found that 25-30% of patients with BD had severe cognitive deficits. 80, 84 On the other hand, three other studies have attempted to identify cognitive subgroups of BD with a data-driven approach (rather than arbitrary cut-off scores) using cluster analysis and latent class analysis. Burdick et al. 85 investigated 136 BD patients using hierarchical cluster analysis and found three clusters according to neurocognitive performance. These clusters included neuropsychologically intact (30%), selectively impaired (30%), and globally impaired (40%) groups. In another cluster analysis study, Lewandowski et al. 74 found four clusters, including neuropsychologically normal (40% of 73 patients with BD), and global cognitive impairment (15% of BD) subgroups. In this study, other BD patients were members of two different selective cognitive impairment clusters. It is important to note that there is also cognitive variability in healthy individuals. These cluster analytical studies did not investigate variability in cognitive functioning in healthy controls and do not tell whether any of the subgroups are more specifically related to BD than controls. In a recent latent class analysis of a large sample of euthymic patients with BD (n = 556) and healthy controls (n = 416), there were four cognitive subgroups clustered (good performance, severe impairment clusters, and two groups with modest deficits in executive functions, processing speed, and verbal memory) based on performance of patients and healthy individuals on executive functions tests (response inhibition and reasoning/problem solving). 86 In comparison to healthy controls, a larger proportion of BD patients were members of the severe impairment cluster (27% vs 5.3%). In conclusion, like schizophrenia, BD has several neurocognitive subgroups, including neuropsychologically normal groups and several clusters with varying levels of cognitive deficits.
Cross-diagnostic investigation of cognitive subgroups
Cross-diagnostic data-driven approaches, such as latent class analysis and cluster analysis, can provide an opportunity to group individuals without considering their diagnoses. These methods can potentially define cognitive subgroups, including the ones that are common to both disorders or unique to one of them. To date, a vast majority of available datadriven studies investigating cognitive subgroups have investigated within diagnosis rather than crossdiagnostic heterogeneity.
Only two studies have investigated cognitive subgroups using cluster analysis or latent class analysis in a cross-diagnostic sample (Lewandowski et al. 74 and Bora et al. 87 ). Using K-means cluster analysis, Lewandowski et al. 74 supported a four-cluster solution, including a 'neuropsychologically normal' cluster, a globally and substantially impaired cluster, and two clusters of mixed neurocognitive profiles. Schizophrenia and BD were distributed amongst all clusters, although patients with schizophrenia were more likely to be members of the global impairment cluster than the neuropsychologically normal cluster (the opposite was true for BD). In another study, Bora et al. 87 investigated the heterogeneity of nonsocial and social cognitive functions (reasoning and decoding aspects of ToM) using latent class analysis. The findings of this study supported four clusters, including the neuropsychologically normal cluster, the severe impairment cluster, and two subgroups of mixed neurocognitive profiles (selective impairment . In this study, compared to BD, a significantly larger proportion (27.8% vs 9.3%) of schizophrenia patients were members of the severe impairment group and a smaller percentage (9.3% vs 25.6%) of schizophrenia patients were included in the cognitively normal subgroup. Importantly, an equal proportion of patients with schizophrenia and BD were members of mixed neurocognition clusters (approximately 60% from each of the two groups).
Good cognitive functioning and premorbid and post-onset characteristics in BD and schizophrenia
Many patients with BD and a small minority of patients with schizophrenia have normal or supranormal cognitive abilities. A relatively large proportion of patients with BD have good cognitive skills and this fact is important for explaining observations suggesting a relation among BD, creativity, and premorbid scholastic achievement. [11] [12] [13] It is likely that a neurobiologically distinct subtype of BD might be characterized by normal neurodevelopment and cognitive functioning and it can be hypothesized that individuals in this subgroup of BD would outperform many healthy controls in scholastic achievement thanks to the advantage of some temperamental characteristics related to BD (i.e., goal-directed, positive approach). 13 Also, the combination of BD-related temperamental characteristics and the absence of developmental cognitive impairment can explain the association between artistic/scientific achievement and creativity and bipolar diathesis. 12, 88 It is important to note that there have been some conflicting results in studies investigating the relation between above-average scholastic achievement/intellectual abilities and risk for BD. 62, 64, 66, [89] [90] [91] [92] However, two large conscript studies provided strong evidence for the relation among risk for BD, above-average scholastic achievement, and good premorbid cognitive functioning. Tiihonen et al. 67 clearly showed that increased risk for BD was significantly associated with good performance in arithmetic abilities. MacCabe et al. 65 reported that the students with the best grades had a nearly fourfold increased risk for BD. There is limited evidence for clinical differences between BD patients with good cognitive function and other cognitive subtypes. Occupational functioning was found to be significantly better in the cognitively normal subgroup in the study by Burdick et al. 85 A smaller proportion of patients with schizophrenia have normal or near-normal cognitive functions. 69, 93 Schizophrenia patients in this group might have better premorbid functioning. 94 However, unlike BD, the evidence does not suggest a relation between risk for schizophrenia and scholastic achievement. This is a striking apparent difference between schizophrenia and BD.
Severe cognitive impairment and premorbid and post-onset characteristics in BD and schizophrenia
Many individuals with schizophrenia and a sizeable minority of individuals with BD are included in cognitive subgroups of patients with severe and widespread cognitive impairment. In schizophrenia, patients in cognitive subgroups characterized by severe deficits might have higher negative symptom ratings. 95 Schizophrenia patients in the severe impairment cognitive subgroup might have more brain-imaging abnormalities than schizophrenia patients with near-normal cognition. 96, 97 Emerging evidence also suggests that there might be specific genetic risk factors for the schizophrenia cognitive subgroup with severe impairment. 95, 98 A sizeable minority of patients with BD also have severe cognitive deficits comparable to schizophrenia. Also, the risk for BD is not only associated with good scholastic achievement but also with low premorbid cognitive functioning and scholastic underachievement. Overall, these findings suggest a Ushaped relation between premorbid cognitive impairment and risk for BD in which both poor and good premorbid cognitive/scholar functioning predict BD in adulthood and risk for BD. No studies have investigated the neurobiological and genetic correlates of membership to the BD subgroup with severe cognitive deficits. However, it has been hypothesized that severe cognitive deficits in BD might be evident only in individuals who share common genetic risk factors with schizophrenia. 13 It can be argued that BD associated with genetic risk factors for schizophrenia might have a similar trajectory of cognitive development to schizophrenia, and that cognitive development in other BD patients might be normal (Fig. 1) .
As a summary, evidence suggests that there are three to four cognitive subgroups within both schizophrenia and BD, including cognitively normal and severe impairment clusters.
Cognitive heterogeneity might have an important role in explaining contradictory findings for differences between schizophrenia and BD in both disorders. For example, studies who recruited a higher proportion of individuals with schizophrenia from the severe cognitive impairment cluster or included a higher proportion of BD patients from the good cognitive performance subgroup were likely to find more significant differences for social and non-social cognition between schizophrenia and BD, including the first-episode, prodromal, and premorbid stages.
CONCLUSION
Neuropsychological studies investigating differences between schizophrenia and BD have reported conflicting findings; however, their findings have not supported the specificity of cognitive or socialcognitive deficits to schizophrenia, including the premorbid and early stages of both disorders. Neuropsychological studies treating schizophrenia and BD as two distinct and cognitively homogenous diagnostic groups are not likely to show strong evidence for between-group difference. It is important to acknowledge that there are multiple cognitive subgroups and that individuals from each diagnostic category are members of these clusters. Differences between schizophrenia and BD are driven by the relative proportions of individuals in the cognitive clusters. Defining cognitive subgroups within schizophrenia and BD can have implications for management (i.e. target groups for cognitive rehabilitation).
It is also important to mention a number of limitations in the available studies investigating cognitive heterogeneity in schizophrenia and BD. Many of the studies, especially in BD, have used arbitrary cut-off scores rather than data-driven methods. Also, cluster analysis has been the method of choice in most data-driven studies. However, other methods, including latent class analysis, can have advantages over cluster analysis, including yielding a smaller misclassification rate, the ability to choose the number of clusters more objectively based on the tests of goodness of fit, and being based on a probabilistic model that describes the distribution of original research data instead of finding clusters with chosen distance measures that are theoretical or arbitrary. 99 Another limitation is that cognitive heterogeneity has been investigated mostly in chronic samples with BD and schizophrenia. Therefore, there is a need for further studies investigating cognitive heterogeneity in early and premorbid stages of the disorder. An important limitation is the cross-sectional nature of available studies and there is a need for further studies investigating the of neurocognitive clusters in schizophrenia and BD. Also, sample sizes of many of the available studies were small and clinical and functional correlates of cluster membership need to be further investigated. Future studies investigating neurobiological, brain imaging and genetic factors related to specific cognitive subgroups in schizophrenia and BD can be helpful in developing a more valid diagnostic system of major psychoses.
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